Dividend13 May 2026, 03:16 pm
GlaxoSmithKline Pharma Recommends ₹57 Dividend; Sets AGM Date
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd's board has recommended a final dividend of ₹57 per equity share for the year ended March 31, 2026, subject to shareholder approval at the AGM. The company has fixed the AGM date as June 30, 2026, and the record date for dividend entitlement as May 29, 2026. Payment will be made on or after July 1, 2026. The board also approved the audited financial results for the quarter and year ended March 31, 2026.
Key Highlights
- Final dividend of ₹57 per share recommended for FY26, pending shareholder approval.
- AGM scheduled for June 30, 2026, via video conferencing.
- Record date for dividend eligibility is set as May 29, 2026.
- Audited financial results for the quarter and year ended March 31, 2026, approved.
- Company confirms non-applicability of annual disclosure as a Large Corporate.
Price Impact
More from GLAXO